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Abstract
Results from the Multiethnic Cohort Study demonstrated significant differences in lung can-
cer risk among cigarette smokers from five different ethnic/racial groups. For the same num-
ber of cigarettes smoked, and particularly among light smokers, African Americans and
Native Hawaiians had the highest risk for lung cancer, Whites had intermediate risk, while
Latinos and Japanese Americans had the lowest risk. We analyzed urine samples from
331–709 participants from each ethnic group in this study for metabolites of phenanthrene, a
surrogate for carcinogenic polycyclic aromatic hydrocarbon exposure. Consistent with their
lung cancer risk and our previous studies of several other carcinogens and toxicants of ciga-
rette smoke, African Americans had significantly (p<0.0001) higher median levels of the two
phenanthrene metabolites 3-hydroxyphenanthrene (3-PheOH, 0.931 pmol/ml) and phenan-
threne tetraol (PheT, 1.13 pmol/ml) thanWhites (3-PheOH, 0.697 pmol/ml; PheT, 0.853
pmol/ml) while Japanese-Americans had significantly (p = 0.002) lower levels of 3-PheOH
(0.621 pmol/ml) thanWhites. PheT levels (0.838 pmol/ml) in Japanese-Americans were not
different from those of Whites. These results are mainly consistent with the lung cancer risk
of these three groups, but the results for Native Hawaiians and Latinos were more complex.
We also carried out a genomewide association study in search of factors that could influence
PheT and 3-PheOH levels. Deletion ofGSTT1 explained 2.2% of the variability in PheT,
while the strongest association, rs5751777 (p = 1.8x10-62) in theGSTT2 gene, explained
7.7% of the variability in PheT. These GWAS results suggested a possible protective effect
of lowerGSTT1 copy number variants on the diol epoxide pathway, which was an unex-
pected result. Collectively, the results of this study provide further evidence that different pat-
terns of cigarette smoking are responsible for the higher lung cancer risk of African
Americans than of Whites and the lower lung cancer risk of Japanese Americans, while
other factors appear to be involved in the differing risks of Native Hawaiians and Latinos.
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Introduction
Lung cancer is the leading cause of cancer death in both men and women in the U.S., with
more than 158,000 deaths in 2015, approximately 90% of which are caused by cigarette smok-
ing [1]. Worldwide in 2012 there were 1,589,800 deaths from lung cancer, about 3 per minute
[2]. Cigarette smoking accounts for 80% of the worldwide lung cancer burden in males and at
least 50% in females [3]. Diminishing this horrible death toll by science-based tobacco control
policies and related approaches to prevention of lung cancer is a critical goal of cancer research.
An understanding of the mechanisms by which smoking causes lung cancer is one approach to
reach this goal.
Results from the Multiethnic Cohort (MEC) study provide a potentially important lead for
understanding mechanisms of smoking-induced lung cancer. This study demonstrated that,
for the same number of cigarettes smoked, and particularly at low levels of smoking, African-
Americans and Native Hawaiians had a significantly higher risk for lung cancer than Whites
while the risks of Latinos and Japanese-Americans were significantly lower than those of
Whites [4]. Our hypothesis is that there are phenotypic and genotypic differences among these
groups that could account for their differing risks for lung cancer. Thus, we have analyzed
urine samples from subjects in each ethnic group for metabolites of carcinogens and toxicants
which are found in tobacco smoke and have also carried out genome wide association studies
(GWAS) in search of common genetic variants that might predict differences in levels of these
metabolites [5–8]. The results to date demonstrate important differences in levels of metabo-
lites of nicotine, the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-
1-butanone (NNK), acrolein, crotonaldehyde, and benzene among the ethnic groups which
may contribute to the observed differences in lung cancer susceptibility in the MEC [5–8]. We
have also observed strong relationships between polymorphisms in certain genes–CYP2A6,
UGT2B10, and GSTT1 –and concentrations of specific metabolites [5–8].
Polycyclic aromatic hydrocarbons (PAH) are a large group of structurally related com-
pounds formed during the incomplete combustion and pyrolysis of organic matter. Common
sources of exposure to PAH include polluted air, occupational exposures which occur in the
aluminum and coke production industries and in roofing and paving with coal tar, consump-
tion of broiled food, and cigarette smoking [9,10]. The planar PAHmolecules, of which the
most abundant have 3–5 aromatic rings, always occur together as mixtures. Many individual
PAH demonstrate strong carcinogenic activity in the lung and other tissues of laboratory ani-
mals, and certain occupations associated with PAH exposure are considered carcinogenic to
humans [9]. Benzo[a]pyrene, a widely studied prototypic and highly carcinogenic PAH, is also
classified as carcinogenic to humans [9]. PAH are considered to be among the principal causes
of lung cancer in cigarette smokers [11]. Phenanthrene, with 3 angular rings, is a typical mem-
ber of the PAH class although it lacks significant carcinogenicity [9]. Phenanthrene metabolites
have been widely used as dosimeters of PAH exposure because their levels vary with those of
carcinogenic PAH metabolites and, due to the higher concentration of phenanthrene in PAH
mixtures, phenanthrene metabolites are more readily quantified [12]. In the study reported
here, we quantified 3-hydroxyphenanthrene (3-PheOH) and phenanthrene tetraol (PheT)
(Fig 1) in the urine of smokers from the five different ethnic groups of the MEC, and carried
out a GWAS to investigate genes associated with 3-PheOH and PheT levels in these smokers.
Materials and Methods
Subjects
Approval for this study, including the consent procedure, was obtained from the Institutional
Review Boards of the University of Minnesota, the University of Hawaii, and the University of
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Southern California. Study participants provided written consent. IRB Code Number:
0912M75654. The subjects in this study are a subgroup of current smokers from the Multieth-
nic Cohort study (MEC). The MEC is a prospective cohort study investigating the association
of genetic and lifestyle factors with chronic diseases in a population with diverse ethnic back-
grounds [13]. The cohort consists of 215,251 men and women, ages 45 to 75 at baseline,
belonging mainly to one of the following five ethnic/racial groups: African Americans, Native
Hawaiians, Whites, Latinos, and Japanese Americans. Potential participants were identified
and recruited between 1993 and 1996 in Hawaii and California (mainly Los Angeles County)
through voter registration lists, drivers’ license files, and Health Care Financing Administration
data. Each participant completed a mail-in self-administered questionnaire, which included
questions regarding demographic, dietary, lifestyle, smoking, and other exposure factors.
Approximately 10 years after their entry into the MEC, 2,393 current smokers participated
in the MEC bio-specimen sub-cohort where a blood sample and a first morning urine sample
(subjects recruited in California) or overnight urine sample (subjects recruited in Hawaii) was
collected. Participants also completed an epidemiologic questionnaire, smoking history ques-
tionnaire and medication record. The overnight urine sample was collected starting between 5
pm and 9 pm (depending on the subject) and includes all urine passed during the night as well
as the first morning urine. All urine was kept on ice until processing. Aliquots were subse-
quently stored in a -80°C freezer until analysis. Approval for this study, including the consent
procedure, was obtained from the Institutional Review Boards of the University of Minnesota,
the University of Hawaii, and the University of Southern California.
Overnight or first morning urine was used to measure total nicotine equivalents (TNE),
which includes the sum of nicotine and its metabolites nicotine glucuronide, cotinine, cotinine
glucuronide, 30-hydroxycotinine, 30-hydroxycotinine glucuronide, and nicotine N-oxide [5],
total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)[7], S-phenylmercapturic acid
(SPMA)[14], 3-hydroxypropylmercapturic acid (3-HPMA)[8], 3-hydroxy-1-methylpropyl-
mercapturic acid (HMPMA)[8] as well as PheT and PheOH, for which the methods are
described below. Creatinine was analyzed using a colorimetric microplate assay (CRE34-K01)
purchased from Eagle Bioscience (http://stores.eaglebio.com/creatinine-microplate-assay-kit).
Fig 1. Metabolism of phenanthrene to 3-PheOH and PheT.
doi:10.1371/journal.pone.0156203.g001
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Statistical methods
For this analysis, 2,310 subjects were retained. These subjects had TNE>1.27 nmol/ml
(4-times the limit of quantitation) [5] and had either PheT or 3-PheOH measured. Of the
2,310 subjects, 14 subjects were missing measures of PheT and 56 subjects were missing mea-
sures of 3-PheOH.
Additionally, among the subjects retained for this analysis, participants who were missing
measures of BMI or cigarettes per day (CPD) at the time of urine collection were imputed
using the Markov Chain Monte Carlo method and PROCMI statement from the SAS v9.2 soft-
ware (SAS institute, Cary, NC). Details regarding the imputation have been published [5,7].
To examine the correlation between PheT, 3-PheOH and measures of smoking [cigarettes
per day (CPD) and TNE], Pearson’s partial correlation coefficients (r) were adjusted for age,
sex and race/ethnicity and creatinine levels (natural log). The Wilcoxon Mann-Whitney test
was used to compare the rank of PheT and 3-PheOH levels across race/ethnicity. Also, the
covariate-adjusted geometric means for PheT and 3-PheOH were computed for each ethnic/
racial group at the mean covariate vector. We used four multivariable linear models. The first
adjusted for the following predictors: age at time of urine collection (continuous), sex (if appli-
cable), race, BMI (natural log) and creatinine levels (natural log) and the second additionally
adjusted for TNE. The remaining two models did not include creatinine levels. To better meet
model assumptions, the measures of PheT and 3-PheOH were transformed by taking the natu-
ral log. For ease of interpretation, the values presented in the tables were back-transformed as
geometric means to their natural scale.
Analysis of 3-PheOH and PheT
These analyses were carried out essentially as described previously [15,16]. Certain modifica-
tions were made in the 3-PheOH assay to accommodate the large number of samples. The
assay was carried out on 350 μL samples of urine, using 96-well plates. The first solid-phase
extraction was performed on an Isolute (Biotage) 400 mg supported liquid-liquid extraction
plate with elution by toluene. The samples were further purified on 96-well plates containing
30 mg per well Copper Phthalocyanine Rayon, then silylated and analyzed by GC-electron
impact-MS as essentially previously described. Among blind duplicate samples, there was an
inter-batch CV of 12.2% for PheT and 19.7% for 3-PheOH. The intra-batch CVs were 5.8%
and 9.5% for the respective metabolites. Each batch contained approximately the same number
of subjects from each sex and ethnic group.
Genetic Methods
We genotyped a total of 2,418 current smokers using the Illumina Human1M-Duo BeadChip
(1,199,187 SNPs), previously described elsewhere [6]. We also imputed variants in the 1000
Genomes Project (http://www.1000genomes.org/) using SHAPEIT [17] and IMPUTE2 [18]
with a cosmopolitan reference panel with all groups included. Post imputation, SNPs were fil-
tered with an IMPUTE2 info score0.30 and minor allele frequency (MAF)>1% in any MEC
ethnic group. For PheT and 3-PheOH, a total of 2,225 and 2,185, respectively, study partici-
pants with complete genotype and phenotype data, and 11,892,802 SNPs/indels (1,131,426
genotyped and 10,761,376 imputed) were included in the final analyses. The GWAS analyses
were adjusted for age, sex, BMI, TNE, race and principal components, with a p-value cut-off of
5x10-8 for genome-wide significance. Among regions with multiple globally significant associa-
tions we used conditional models to determine the leading loci. We also performed ethnic-spe-
cific analyses to discover population specific loci of importance.
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A GSTT1 deletion polymorphism was successfully genotyped among 2,111 individuals via
TaqMan, using a pre-designed TaqMan GSTT1 copy number assay (Hs00010004), and run on
the 7900HT Fast Real-Time System (Life Technologies, Foster City, CA). Copy number counts
were calculated with the Life Technologies CopyCaller v2.0 software.
For the smoking variables, least-square means (or geometric means) were estimated and
compared between populations, in this case, copies of GSTT1. R-squared values were used to
assess percentage of variability of PheT and 3-PheOH accounted for by the variants examined.
Results
Characteristics of the study subjects whose urine was analyzed for 3-PheOH or PheT, and infor-
mation on their cigarette consumption and TNE are summarized in Table 1. There were 331–
709 subjects per ethnic group, with mean ages ranging from 60–65 years, and BMI from 24.4–
26.9 kg/m2. Creatinine ranged from a low of 54 mg/dL inWhites to a high of 89 mg/dL in Afri-
can-Americans, and cigarettes per day from a low of 7.1 in Latinos to a high of 20 inWhites.
TNE were lowest (27.2 nmol/mL) in Japanese Americans and highest (44.4 nmol/mL) in Afri-
can Americans. All characteristics were significantly different among the groups (P<0.0001).
Males smoked significantly more cigarettes per day than females in all groups except Afri-
can Americans (p = 0.08). TNE were significantly higher in males than in females among Afri-
can Americans, Whites, and Japanese Americans (p’s< = 0.01).
Correlations among 3-PheOH, PheT, TNE, total NNAL, SPMA, 3-HPMA, and HMPMA
are summarized in Table 2, for the entire group and separately for males and females. All corre-
lations were statistically significant (most with P<0.0001).
Table 1. Main characteristics of study participantsa stratified by race/ethnicity.
African Americans Native Hawaiians Whites Latinos Japanese
Americans
Median (Interquartile)
p-values
All 369 331 445 456 709
Age (years) 64 (59–69) 60 (56–65) 62 (58–68) 65 (61–70) 62 (58–69) <0.0001
BMI (kg/m2) 26.9 (23.4–30.6) 26.8 (24.1–30.8) 24.7 (22.0–28.0) 26.5 (24.1–29.9) 24.4 (21.9–27.0) <0.0001
Creatinine (mg/dL) 89 (53–140) 60 (38–91) 54 (33–85) 77 (51–120) 55 (34–89) <0.0001
Cigarettes per day 10 (5–15) 15 (8–20) 20 (10–20) 7.1 (4–12) 12 (10–20) <0.0001
TNE (nmol/mL) 44.4 (26.8–73.8) 31.3 (20.0–48.5) 36.3 (21.9–61.5) 32.2 (20.9–53.6) 27.2 (15.8–43.5) <0.0001
Males 112 120 193 239 404
Age (years) 63 (58–66) 63 (58–68) 62 (59–67) 65 (62–71) 62 (58–68) <0.0001
BMI (kg/m2) 26.3 (23.1–28.4) 26.8 (24.3–30.6) 25.8 (23.3–28.0) 25.8 (23.7–28.7) 24.8 (22.7–27.4) <0.0001
Creatinine (mg/dL) 120 (81–170) 75 (51–120) 71 (48–110) 90 (58–140) 70 (44–110) <0.0001
Cigarettes per day 10 (6.2–20) 19 (10–20) 20 (15–25) 10 (5–15) 15 (10–20) <0.0001
TNE (nmol/mL) 54.0 (32.0–92.7) 33.4 (22.2–52.0) 42.4 (25.2–78.4) 34.6 (21.9–59.1) 30.0 (17.9–47.8) <0.0001
Females 257 211 252 217 305
Age (years) 64 (59–71) 59 (56–64) 62 (58–69) 64 (60–69) 62 (58–69) <0.0001
BMI (kg/m2) 27.4 (23.5–31.5) 26.8 (23.9–31.1) 23.8 (21.0–27.8) 27.2 (24.2–30.7) 23.5 (20.7–26.5) <0.0001
Creatinine (mg/dL) 79 (49–130) 54 (33–80) 47 (29–67) 65 (45–94) 43 (27–66) <0.0001
Cigarettes per day 10 (5–15) 12 (8–20) 15 (7.5–20) 6 (4–10) 10 (7–15) <0.0001
TNE (nmol/mL) 41.5 (25.9–66.1) 30.1 (19.1–46.0) 31.6 (20.3–50.7) 31.7 (18.3–50.1) 21.9 (13.6–35.3) <0.0001
TNE, total nicotine equivalents
a Includes all study participants with either PheT or 3-PheOH measures.
doi:10.1371/journal.pone.0156203.t001
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The strongest correlations in the overall group were between 3-PheOH and PheT (Pearson’s
r = 0.49–0.59).
Because of the large differences in creatinine levels among the groups, metabolite levels
were expressed per mL urine. Medians and interquartile ranges for 3-PheOH and PheT are
summarized in Table 3. The highest levels of 3-PheOH, 0.931 pmol/mL urine, were found in
African Americans, and these were significantly higher (P<0.0001) than those in Whites, 0.697
pmol/mL urine. The lowest levels of 3-PheOH, 0.621 pmol/mL urine were found in Japanese
Americans and these were significantly lower than in Whites (P = 4.50x10-3). High levels of
PheT, 1.13 pmol/mL urine, were also found in African Americans, and were significantly
higher than in Whites (0.853 pmol/mL urine, P = 0.0001). PheT levels in Japanese Americans
were not significantly different from those in Whites. When dichotomized by sex, African
Americans had higher levels of both 3-PheOH and PheT than Whites and Japanese Americans
had lower levels than Whites, and most differences were significant.
Levels of 3-PheOH in the urine of Latinos were similar to those in Whites while levels in
Native Hawaiians were significantly lower than in Whites (P = 0.0107). Levels of PheT in the
urine of Latinos were significantly higher than in Whites (P<0.0001) while those of Native
Hawaiians were similar to Whites. When dichotomized by sex, most of these comparisons
were non-significant or borderline, except PheT in Latino females, which was significantly
higher than in Whites (P = 7.00x10-4).
Table 3. Median and interquartile range for measures of 3-PheOH and PheT.
All Males Females
N Median (Interquartile
range)
p-value when
compared to
Whitesa
N Median (Interquartile
range)
p-value when
compared to
Whites
N Median (Interquartile
range)
p-value when
compared to
Whites
3-PheOH
(pmol/mL)
African
Americans
358 0.931 (0.564–1.63) <0.0001 110 1.18 (0.741–1.84) 4.00x10-4 248 0.814 (0.528–1.46) <0.0001
Native
Hawaiians
321 0.624 (0.426–0.888) 0.0107 117 0.680 (0.482–1.06) 0.0356 204 0.596 (0.385–0.831) 0.237
Whites 432 0.697 (0.437–1.08) 188 0.864 (0.488–1.38) 244 0.604 (0.402–0.916)
Latinos 448 0.725 (0.463–1.15) 0.229 236 0.810 (0.536–1.42) 0.797 212 0.632 (0.400–0.989) 0.607
Japanese
Americans
695 0.621 (0.414–0.922) 4.50x10-3 397 0.686 (0.468–1.01) 3.10x10-3 298 0.533 (0.350–0.803) 9.90x10-3
p-value <0.0001 <0.0001 <0.0001
PheT (pmol/
mL)
African
Americans
367 1.13 (0.617–2.22) 1.00x10-4 112 1.40 (0.835–2.65) 0.0150 255 0.959 (0.565–2.05) 0.0001
Native
Hawaiians
329 0.829 (0.484–1.35) 0.179 119 1.10 (0.707–1.64) 0.530 210 0.720 (0.420–1.19) 0.484
Whites 443 0.853 (0.506–1.64) 193 1.17 (0.639–2.31) 250 0.699 (0.446–1.40)
Latinos 453 1.14 (0.694–1.86) 1.00x10-4 238 1.26 (0.788–2.07) 0.222 215 0.994 (0.579–1.64) 7.00x10-4
Japanese
Americans
704 0.838 (0.503–1.39) 0.322 402 0.966 (0.605–1.67) 0.0477 302 0.672 (0.422–1.15) 0.356
p-value <0.0001 <0.0001 <0.0001
a p-value using the Wilcoxon Mann-Whitney test.
doi:10.1371/journal.pone.0156203.t003
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Geometric means of 3-PheOH and PheT, expressed per mL of urine, are presented in
Table 4. In Model 1, adjusting for age, sex, and BMI, African Americans had the highest levels
of both 3-PheOH and PheT and Japanese Americans the lowest; these levels were significantly
different from those in Whites. In Model 2, additionally adjusting for TNE, similar results were
obtained except that the Japanese Americans’ 3-PheOH levels were not significantly different
from those of Whites, and their PheT levels were significantly higher thanWhites. Latinos had
significantly higher levels of 3-PheOH and PheT than Whites in both models while Native
Hawaiians had lower levels than Whites, and these were significant for 3-PheOH in Model 1.
Additional adjustment for creatinine in Model 1 abolished the significant difference between
African Americans andWhites in levels of 3-PheOH and PheT (data not shown), due to the
relatively high creatinine levels in African Americans (Table 1).
In the GWAS analyses of 3-PheOH and PheT, we observed little evidence of inflation in the
test statistic in the overall multiethnic sample (λ = 1.0; S1 and S2 Figs) or in any single ethnic
group (0.96 λ’s 1.0) for either phenotype. In the overall analysis for PheT, there were 408
globally significant variants located between 24.2–24.4 Mb near the region of glutathione S-
transferase T1 and T2 (GSTT1 and GSTT2) on chromosome 22q11 (S3 Fig, S1 Table). There
were three other rare globally significant associations on chromosomes 1, 6 and 14. The chro-
mosome 1 variant is located in the intronic region of an open reading frame of gene C1orf159,
109 Mb from the GSTM1 gene. The chromosome 6 variant is located within gene PPP1R14C, a
protein phosphatase gene involved in protein synthesis and metabolism, and the chromosome
Table 4. Geometric means of 3-PheOH and PheT.
Model 1a Model 2b
N Geometric means (95% CI) Geometric means (95% CI)
3-PheOH (pmol/mL)
African Americans 358 1.06 (0.984–1.14)† * Ψ 0.848 (0.797–0.901)† § * Ψ
Native Hawaiians 321 0.605 (0.559–0.654)† ‡ * 0.623 (0.585–0.664) ‡ * Ψ
Whites 432 0.713 (0.667–0.762) ‡ § * Ψ 0.674 (0.639–0.712) ‡ *
Latinos 448 0.784 (0.734–0.837)† ‡ § Ψ 0.774 (0.734–0.816)† ‡ § Ψ
Japanese Americans 695 0.593 (0.562–0.626)† ‡ * 0.675 (0.646–0.706) ‡ § *
p-valuec <0.0001 <0.0001
PheT (pmol/mL)
African Americans 367 1.30 (1.19–1.42)† * Ψ 0.992 (0.923–1.07)† § *
Native Hawaiians 329 0.858 (0.782–0.941) ‡ * 0.888 (0.825–0.956) ‡ *
Whites 443 0.927 (0.858–1.00) ‡ * Ψ 0.870 (0.817–0.926) ‡ * Ψ
Latinos 453 1.14 (1.05–1.23)† ‡ § Ψ 1.12 (1.05–1.19)† ‡ § Ψ
Japanese Americans 704 0.821 (0.771–0.875)† ‡ * 0.963 (0.916–1.01)† *
p-valuec <0.0001 <0.0001
a Model 1, adjusted for age, sex, and BMI
b Model 2 additionally adjusted for TNE
c Global p-value
† Significant when compared to Whites
‡ Significant when compared to African Americans
§ Significant when compared to Native Hawaiians
* Significant when compared to Latinos
Ψ Significant when compared to Japanese Americans
doi:10.1371/journal.pone.0156203.t004
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14 variant is near gene TTC6 / FOXA1. As these three variants are rare, we focus our presenta-
tion on the globally significant associations on chromosome 22 near genes GSTT1 and GSTT2.
When the 408 globally significant associations were conditioned on the GSTT1 deletion
polymorphism, there remained 262 globally significant variants; the GSTT1 deletion does not
fully explain the association with PheT (S2 Table). The GSTT1 deletion explains only 2.2% of
the variability in PheT, compared to the strongest association, rs5751777 (p = 1.8x10-62),
which on its own explains 7.7% of the variability in PheT. The deletion allele, which is associ-
ated with significantly lower PheT levels in the overall group (p = 3.4 x 10−16), and in Native
Hawaiians, Whites, and Latinos, varies in frequency across populations from 0.40 in Latinos to
0.66 in Japanese (Table 5). The highly significant associations observed at 22q11 are in part
explained by the GSTT1 deletion (n = 2,097; Table 5). Through forward selection regression
analysis (at a threshold of 1x10-3) of the 262 variants that remained significantly associated
with PheT after adjustment for the GSTT1 deletion polymorphism, we identified 5 indepen-
dent variants including our top association rs5751777 (Table 6). Together, these 5 variants
explained 9.33% of the variability in PheT.
In ethnic specific GWAS analyses for African Americans there were 16 globally significant var-
iants on chromosome 22 near the GSTT2 gene, for Latinos there were 141 globally significant var-
iants, for Japanese Americans there were 206 globally significant variants, for both the Native
Hawaiians andWhites there were 59 globally significant variants near the GSTT2 andGSTTP1
genes (S4–S8 Figs). The GSTT1 deletion polymorphism explained from 0.1% of variability in
PheT among African Americans to 5.7% of the variability in PheT among Latinos (Table 5).
Increasing GSTT1 copy numbers were significantly associated with higher PheT levels
(p = 3.4 x 10−16) in the overall group, and in Native Hawaiians, Whites, and Latinos (Table 5).
There were no globally significant variants for either the overall or the ethnic specific analy-
ses for 3-PheOH using our genomic threshold of p<5x10-8 (S2 Fig).
Discussion
In previous analyses of tobacco smoke carcinogen and toxicant metabolites in urine samples
from the MEC, we have observed that African Americans had the highest TNE levels and
Table 5. Geometric means (95%CI) of PheT (pmol/mL) stratified byGSTT1 copy number variants and race/ethnicity.
GSTT1 copies All African Americans Native Hawaiians Whites Latinos Japanese
Americans
N Geometric
means (95%
CL)a
N Geometric
means (95%
CL)a
N Geometric
means (95%
CL)a
N Geometric
means (95%
CL)a
N Geometric
means (95%
CL)a
N Geometric
means (95%
CL)a
p-value
0 614 0.83 (0.79–
0.88)
75 1.18 (0.98–
1.41)b
75 0.71 (0.62–
0.80)
77 0.72 (0.63–
0.83)
87 0.76 (0.66–
0.89)
300 0.79 (0.74–
0.85)b
9.6 x
10−4
1 963 0.95 (0.91–
0.99)
174 1.25 (1.11–
1.40)b
138 0.86 (0.79–
0.95)
202 0.86 (0.79–
0.94)
185 1.07 (0.97–
1.2)b
265 0.84 (0.79–
0.91)b
7.5 x
10−6
2 520 1.16 (1.09–
1.22)
87 1.28 (1.08–
1.51)
65 1.03 (0.90–
1.17)
142 1.17 (1.06–
1.30)
162 1.37 (1.2–
1.52)b
64 0.93 (0.81–
1.07)
4.6 x
10−4
p-value 3.4x10-16 0.784 3.6x10-4 2.0x10-7 5.1x10-9 0.089
Null frequency 0.47 0.51 0.41 0.4 0.66
Variation
explained
2.20% 0.10% 2.87% 4.20% 5.70% 0.38%
a Adjusted for age, sex, BMI, and TNE
b P-value <0.05 when compared to Whites
doi:10.1371/journal.pone.0156203.t005
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Japanese Americans the lowest, both being significantly different from the intermediate levels
in Whites [5]. Consistent with these observations, African Americans also had the highest lev-
els of NNAL and its glucuronides, metabolites of the tobacco-specific lung carcinogen NNK,
while Japanese Americans had the lowest, and these were significantly different from those in
Whites [7]. Further studies demonstrated completely analogous results for S-phenylmercaptu-
ric acid, a metabolite of the volatile toxicant and carcinogen benzene [14]. In the study reported
here, we have extended these analyses to 3-PheOH and PheT, metabolites of phenanthrene, a
representative PAH. Consistent with the previous studies, we find high levels of 3-PheOH and
PheT in African Americans, and the lowest level of 3-PheOH in Japanese Americans, and these
were significantly different from those in Whites. Overall, these results provide compelling evi-
dence that exposure to representative tobacco smoke carcinogens—NNK, benzene, and PAH
—is highest in African Americans, who are at highest risk for lung cancer in the MEC, and low-
est in Japanese Americans, at lowest risk for lung cancer. Thus, differences in carcinogen expo-
sure from cigarette smoke among these three groups can at least partially explain their
differing risks for lung cancer. African Americans smoke cigarettes differently fromWhites,
extracting more nicotine and more carcinogens per cigarette (Table 1 and [5,7]). This is also
consistent with the observation that, among African Americans, the time to first cigarette upon
waking in the morning is significantly shorter than in Whites [19]. Japanese Americans have a
higher number of CYP2A6 polymorphisms associated with lower nicotine metabolism than
Whites, and consequently need to obtain less nicotine per cigarette and are therefore exposed
to lower amounts of other toxicants and carcinogens thanWhites [20], although that effect was
not so strong in this study, perhaps due to other PAH exposure routes in Japanese Americans.
Hydroxylated PAH such as urinary 3-PheOH and the closely related compound 1-hydroxy-
pyrene are accepted biomarkers of PAH exposure [21]. These simple hydroxylated PAH are
metabolically formed by a cytochrome P450-catalyzed epoxidation of the PAH ring followed
by rearrangement of the epoxide (“the NIH shift”) or by direct oxidation of the PAH ring
[9,10]. These simple metabolic processes favor a direct relationship between PAH exposure
Table 6. Five significant variants remaining from stepwise regression analysis.
Alternate allele frequency in 1000 genomes
Chra SNPb BP Reference
allele
Alternate
allele
African
samples
American
samples
Asian
samples
European
samples
Betac Pd Typee Genef
22 rs5751777 24267047 C T 0.4533 0.5166 0.5087 0.6174 0.3117 1.31E-
45
intergenic GSTT2
22 rs1006771 24314006 G T 0.6565 0.6326 0.5245 0.6649 0.2116 1.41E-
23
UTR3 DDTL
22 rs80020284 24312589 G A 0.2642 0.1188 0.0122 0.0488 -0.3459 6.61E-
17
intronic DDTL
22 rs2154595 24268647 C T 0.2297 0.0608 0 0.0699 -0.3179 2.21E-
12
intergenic GSTT2
22 rs35921388 24401503 C T 0.0996 0.2182 0.3462 0.223 -0.1912 2.85E-
11
ncRNA_exonic GSTTP2
a Chromosome
b Base pair, chromosomal position
c Effect estimate per alternate allele carried
d p-value from test of association
e SNP variant/classification
f Nearest gene designation
doi:10.1371/journal.pone.0156203.t006
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and level of the hydroxylated metabolite in urine. Furthermore, in the case of phenanthrene,
approximately 90% of its excreted metabolites are found in urine, based on studies in rats [22].
Thus urinary 3-PheOH is an excellent biomarker of exposure to phenanthrene, a representative
PAH closely related to carcinogenic PAH such as benz[a]anthracene, chrysene, benzofluor-
anthenes, and benzo[a]pyrene which are simultaneously formed during cigarette smoking by
combustion of tobacco. The NHANES study of 3-PheOH reported levels of this urinary metab-
olite in smokers that are similar to those in our study [12]. The metabolism pathway leading to
PheT is more complex, and interpretation of the resulting data might not be as straightforward
[23]. The initially formed epoxide is hydrated to a dihydrodiol, catalyzed by epoxide hydrolase.
This dihydrodiol is then further oxidized to a dihydrodiol epoxide, which then undergoes
hydrolysis to form PheT. As discussed below, the epoxides potentially can be detoxified by glu-
tathione-S-transferases, which could influence PheT levels. For higher PAH such as benzo[a]
pyrene, the same sequence of reactions resulting in PheT leads to a major ultimate carcinogen,
benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide (BPDE) [10,24,25]. Thus, PheT can be consid-
ered a surrogate for PAH exposure plusmetabolic activation, and levels of PheT in human
urine correlate with those of the tetraol derived from BPDE [26]. In spite of these complexities,
exposure to phenanthrene is a major driving force for PheT formation, as indicated by the cor-
relation between 3-PheOH and PheT (Pearson’s r = 0.49–0.59).
Considerable evidence favors a significant role for PAH as causes of lung cancer in cigarette
smokers [27]. Multiple PAH have been identified in cigarette smoke and some of these are
powerful carcinogens, readily inducing tumors at the site of application, including the lung, as
well as at distant sites [11,28,29]. Subfractions of cigarette smoke condensate enriched in PAH
are tumor initiators on mouse skin, and the combination of cigarette smoke PAH and tumor
promoters or co-carcinogens partially recapitulates the carcinogenic activity of cigarette smoke
condensate in mouse skin experiments [28]. Total levels of established lung carcinogenic PAH
in cigarette smoke are about 50–60 ng/cigarette, similar to levels of the lung carcinogen NNK
[27]. DNA adducts of BPDE have been identified in lung tissue from some smokers, and reac-
tions of BPDE and other PAH diol epoxide metabolites with the p53 tumor suppressor gene
produce adducts at the same sites known to be mutational hot spots in human lung cancer
(although the same pattern is also formed by acrolein) [30–33].
Levels of 3-PheOH were significantly lower in Native Hawaiians than inWhites, which is
consistent with previous observations for TNE and total NNAL. These results suggest that
intake of smoke constituents in Native Hawaiians is less than inWhites, in spite of the fact that
they are at higher risk for lung cancer. We have reported however that urinary levels of the acro-
lein biomarker 3-HPMAwere highest in Native Hawaiians compared to the other MEC groups,
suggesting that endogenous processes related to lipid peroxidation perhaps play a role in the rel-
atively high risk of Native Hawaiians for lung cancer. Levels of PheT were significantly higher in
Latinos than inWhites, and this effect was confined to females. This is different from our obser-
vations with TNE and total NNAL, and requires further study. Collectively, these observations
suggest that there are factors influencing lung cancer susceptibility in Native Hawaiians and
Latinos that have not been recognized in our metabolic and genetic studies to date.
The GWAS demonstrated a signal associated with PheT on chromosome 22 near GSTT1
and GSTT2. While glutathione S-transferases M1 (GSTM1), GSTP1, and GSTA1 are known to
catalyze the detoxification of diol epoxides formed from various PAH, there is scant evidence
that GSTT1 or GSTT2 have activity in the detoxification of PAH epoxides or diol epoxides,
including those formed from phenanthrene [34–39]. To the extent that such activity exists, we
would have expected lower levels of PheT in individuals with both copies of the GSTT1 gene
because the diol epoxide precursor to PheT would be intercepted (Fig 1), but instead we
observed significantly higher levels of PheT in individuals with both copies of the gene
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(Table 5). There is evidence from some previous studies that the GSTT1 deletion is protective,
which would be consistent with our surprising observation of lower PheT levels in the null
individuals, but this requires further study [40]. Apparently, the relationship of GSTT1 and
GSTT2 activity to PheT levels may be more complex than previously thought.
In summary, the results of this study demonstrate higher uptake of carcinogenic PAH, as dem-
onstrated by urinary 3-PheOH and PheT levels, in African American smokers than inWhites
and lower levels in Japanese American smokers. These observations are consistent with our previ-
ous studies demonstrating patterns of nicotine, tobacco-specific nitrosamine, and benzene uptake
in these groups, consistent with their differing risks for lung cancer. The relationships of PAH
uptake to lung cancer risk in Native Hawaiians and Latinos appear to be more complex. We also
observed strong effects ofGSTT1 deletion and a GSTT2 polymorphism on PheT levels, suggesting
previously unknown factors influencing the PAH diol epoxide metabolic activation pathway.
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